Read aloud by your device’s built-in voice. Nothing is sent over the internet.
Trial governance
Registration, ethics, sponsorship, and protocol details for the CARE-PAC trial. Several values are pending; see notes against each item.
- Trial registry (ISRCTN)
- To be confirmed · To be issued at trial registration.
- REC reference
- To be confirmed · Awaiting Research Ethics Committee submission.
- IRAS ID
- To be confirmed · Awaiting IRAS submission.
- Sponsor
- University of Strathclyde
- Protocol version
- v0.1 (draft, March 2026)
- Chief Investigators
- Prof. Roma Maguire and Prof. Ollie Minton
- Funder
- National Institute for Health and Care Research Product Development Award
- Trial duration
- February 2026 – January 2029
Funding acknowledgement
The CARE-PAC project is funded by the National Institute for Health and Care Research Product Development Award. The views expressed are those of the project team and not necessarily those of the National Institute for Health and Care Research or the Department of Health and Social Care.
Sponsorship
The University of Strathclyde is the sponsor of the CARE-PAC trial. Sponsorship arrangements, indemnity, and oversight follow UK Health Research Authority requirements.
Ethics
Ethical approval will be sought from the relevant NHS Research Ethics Committee. Approval references will appear above as soon as they are issued. The trial will be conducted in accordance with the principles of Good Clinical Practice and the Declaration of Helsinki.
Data protection
Personal and clinical data will be handled in accordance with the UK General Data Protection Regulation (UK GDPR), the Data Protection Act 2018, and the trial’s data sharing agreement. Detailed information for participants will be provided in the Participant Information Sheet, available from your care team once recruitment opens.
Want to be involved?
Whether you are a clinician interested in trial sites, a researcher exploring collaboration, or a patient or carer who would like a voice in shaping the system, we would love to hear from you.
Contact the team